Abbott Overview
- Year Founded
-
1888
- Status
-
Public
- Employees
-
114,000
- Stock Symbol
-
ABT
- Investments
-
67
- Share Price
-
$112.31
- (As of Friday Closing)
Abbott General Information
Description
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Contact Information
Website
www.abbott.comCorporate Office
- 100 Abbott Park Road
- Abbott Park
- North Chicago, IL 60064
- United States
Corporate Office
- 100 Abbott Park Road
- Abbott Park
- North Chicago, IL 60064
- United States
Abbott Stock Performance
As of 10-Jan-2025, Abbott’s stock price is $112.31. Its current market cap is $195B with 1.74B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $112.31 | $114.25 | $99.71 - $121.64 | $195B | 1.74B | 5.06M | $3.31 |
Abbott Financials Summary
As of 30-Sep-2024, Abbott has a trailing 12-month revenue of $41.2B.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 206,142,657 | 199,781,963 | 198,142,965 | 257,789,708 |
| Revenue | 41,217,000 | 40,109,000 | 43,653,000 | 43,075,000 |
| EBITDA | 10,242,000 | 10,159,000 | 11,948,000 | 12,239,000 |
| Net Income | 5,767,000 | 5,723,000 | 6,933,000 | 7,071,000 |
| Total Assets | 74,356,000 | 73,214,000 | 74,438,000 | 75,196,000 |
| Total Debt | 14,979,000 | 15,628,000 | 17,716,000 | 19,006,000 |
Abbott Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Abbott Comparisons
Industry
Financing
Details
Abbott Competitors (14)
One of Abbott’s 14 competitors is Novo Nordisk, a Corporation company based in Bagsvaerd, Denmark.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novo Nordisk | Corporation | Bagsvaerd, Denmark | ||||
| GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria | ||||
| Coloplast | Corporation | Humlebaek, Denmark | ||||
| Pfizer Manufacturing Austria | Corporation | Orth An Der Donau, Austria | ||||
| Terumo | Corporation | Tokyo, Japan |
Abbott Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Abbott Patents
Abbott Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240400756-A1 | Aba tri-block copolymer and bioresorbable implants made therewith | Pending | 31-May-2023 | ||
| US-20240382324-A1 | Intravascular stent | Pending | 17-May-2023 | ||
| US-20240374871-A1 | Twisted guidewire | Pending | 11-May-2023 | ||
| US-20240374870-A1 | Guidewire and method of use | Pending | 08-May-2023 | ||
| US-20240367846-A1 | Collapsible, hangable plastic bottle | Pending | 01-May-2023 | B65D1/0292 |
Abbott Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Abbott Investments & Acquisitions (67)
Abbott’s most recent deal was a Merger/Acquisition with Bigfoot Biomedical. The deal was made on 22-Sep-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Bigfoot Biomedical | 22-Sep-2023 | Merger/Acquisition | Monitoring Equipment | ||
| Allergy Therapeutics | 14-Jul-2023 | Secondary Transaction - Open Market | Other Commercial Services | ||
| Cardiovascular Systems | 27-Apr-2023 | Merger/Acquisition | Surgical Devices | ||
| Walk Vascular | 02-Sep-2021 | Merger/Acquisition | Therapeutic Devices | ||
| GLP Systems | 27-Jun-2019 | Merger/Acquisition | Machinery (B2B) |
Abbott ESG
Risk Overview
Risk Rating
Updated May, 31, 2024
22.21 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,104
Rank
Percentile
Healthcare
Industry
of 588
Rank
Percentile
Medical Devices
Subindustry
of 200
Rank
Percentile
Abbott Exits (13)
Abbott’s most recent exit was on 14-Jul-2023 from Allergy Therapeutics. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Allergy Therapeutics | 14-Jul-2023 | Completed |
|
||
| Dairy Farming (Fonterra / Abbott) | 11-Jul-2014 | Completed |
|
||
| CeutiCare | 01-Jan-2011 | Completed |
|
||
| Starlims Technologies | 22-Mar-2010 | Completed |
|
||
| VytronUS | 29-Jun-2009 | Early Stage VC | Completed |
|
Affiliates
Subsidiaries (13)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Bigfoot Biomedical | Milpitas, CA | 2014 | |
| Topera | Menlo Park, CA | 2008 | |
| Abbott Ventures | Chicago, IL | 2004 | |
| Abbott Laboratories Pension Plan for Former Basf and Former Solvay employees | North Chicago, IL | 2001 | |
| Visiogen | Irvine, CA | 2001 |
Abbott FAQs
-
When was Abbott founded?
Abbott was founded in 1888.
-
Where is Abbott headquartered?
Abbott is headquartered in North Chicago, IL.
-
What is the size of Abbott?
Abbott has 114,000 total employees.
-
What industry is Abbott in?
Abbott’s primary industry is Pharmaceuticals.
-
Is Abbott a private or public company?
Abbott is a Public company.
-
What is Abbott’s stock symbol?
The ticker symbol for Abbott is ABT.
-
What is the current stock price of Abbott?
As of 10-Jan-2025 the stock price of Abbott is $112.31.
-
What is the current market cap of Abbott?
The current market capitalization of Abbott is $195B.
-
What is Abbott’s current revenue?
The trailing twelve month revenue for Abbott is $41.2B.
-
Who are Abbott’s competitors?
Novo Nordisk, GlaxoSmithKline Consumer Nigeria, Coloplast, Pfizer Manufacturing Austria, and Terumo are some of the 14 competitors of Abbott.
-
What is Abbott’s annual earnings per share (EPS)?
Abbott’s EPS for 12 months was $3.31.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
